Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival
Oncology · 2024
DOI: 10.1159/000542774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Brian Carr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Portal Vein, Venous Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Introduction
Presence of macroscopic portal vein thrombosis (PVT) in patients with hepatocellular carcinoma (HCC) has been found to be a major poor prognosis characteristic.
Aims
The aim of the study was to examine patients with PVT for their clinical characteristics and factors related to both PVT and survival.
Methods
A large HCC database containing 1,094 patients with PVT and 2,513 patients without PVT was examined. Patients had routine baseline serum liver parameters and alpha-fetoprotein (AFP) levels measured, as well as radiological assessment of maximum tumor diameter (MTD), tumor number, presence of macroscopic PVT, plus survival.
Results
The percent of patients with PVT increased with increase in both MTD and serum AFP levels and liver parameter levels were worse in patients with PVT than without it. A logistic regression model showed that the combination of MTD >5 cm plus AFP >100 IU/mL plus albumin
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.
- National Institute of Gastroenterology, IRCCS "Saverio de Bellis", Bari, Italy.
- Department of Surgery, Inonu University Faculty of Medicine, Malatya, Turkey.
Förderung
- NCI NIH HHS
Zitieren
APA
Carr, B., Donghia, R., & Yilmaz, S. (2024). Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival. Oncology. https://doi.org/10.1159/000542774
Vancouver
Carr B, Donghia R, Yilmaz S. Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival. Oncology. 2024. doi:10.1159/000542774
BibTeX
@article{Carr2024,
author = {Carr, Brian and Donghia, Rossella and Yilmaz, Sezai},
title = {Characteristics of HCC Patients with Portal Vein Thrombosis: Albumin and Survival},
journal = {Oncology},
year = {2024},
doi = {10.1159/000542774}
}
EUVIMED